1.
Katja Sockel, Martin Wermke, Jörgen Radke, Alexander Kiani, Markus Schaich, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede, Uwe Platzbecker. Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse. haematol [Internet]. 2011Oct.4 [cited 2024May21];96(10):1568-70. Available from: https://haematologica.org/article/view/6110